BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6311575)

  • 1. Dynorphin-(1-13): the effect of in vivo treatment on opiate bindings in vitro.
    Jen MF; Garzon J; Loh HH; Lee NM
    Eur J Pharmacol; 1983 Jul; 91(1):95-9. PubMed ID: 6311575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased dihydromorphine and D-ALA2-D-LEU5-enkephalin binding in vitro after dynorphin pretreatment in mice in vivo.
    Jen MF; Garzón J; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1813-6. PubMed ID: 6130446
    [No Abstract]   [Full Text] [Related]  

  • 3. Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro.
    Garzón J; Jen MF; Sánchez-Blázquez P; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1789-92. PubMed ID: 6130441
    [No Abstract]   [Full Text] [Related]  

  • 4. Regional interactions of opioid peptides at mu and delta sites in rat brain.
    Hewlett WA; Barchas JD
    Peptides; 1983; 4(6):853-8. PubMed ID: 6324140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin1-13: interaction with other opiate ligand bindings in vitro.
    Garzón J; Sánchez-Blázquez P; Gerhart J; Loh HH; Lee NM
    Brain Res; 1984 Jun; 302(2):392-6. PubMed ID: 6329465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
    Ishizuka Y; Oka T
    Tokai J Exp Clin Med; 1987 Mar; 12(1):11-7. PubMed ID: 2835832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of human B-endorphin on the binding of different opiates to mouse brain membranes.
    Garzón J; Sánchez-Blázquez P; Lee NM
    Life Sci; 1983; 33 Suppl 1():279-82. PubMed ID: 6319877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate receptor binding profile in the rabbit cerebellum and brain membranes.
    Ho CL; Hammonds RG; Li CH
    Biochem Pharmacol; 1985 Apr; 34(7):925-31. PubMed ID: 2985086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer analysis of the effect of beta-endorphin and dynorphin and related compounds on opioid binding to mouse brain membrane.
    Landahl HD; Garzon J; Lee NM
    Comput Biol Med; 1989; 19(3):151-62. PubMed ID: 2566453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin A: inhibitory effect on other opiate ligand bindings in the mouse brain.
    Garzón J; Sánchez-Blázquez P; Gerhart J; Loh HH; Lee NM
    Biochem Pharmacol; 1984 Aug; 33(16):2609-14. PubMed ID: 6147144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin.
    James IF; Chavkin C; Goldstein A
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7570-4. PubMed ID: 6130527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid-specific recognition sites of the mu- and the delta-type in rat striatum after lesions with kainic acid.
    Antkiewicz-Michaluk L; Havemann U; Vetulani J; Wellstein A; Kuschinsky K
    Life Sci; 1984 Jul; 35(4):347-55. PubMed ID: 6087059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic ethanol induces changes in opiate receptor function and in met-enkephalin release.
    Lucchi L; Rius RA; Govoni S; Trabucchi M
    Alcohol; 1985; 2(2):193-5. PubMed ID: 2990502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-endorphin does not protect alkylation of opiate receptor by N-ethylmaleimide.
    Westphal M; Hammonds RG; Ferrara P; Li CH
    Int J Pept Protein Res; 1985 Apr; 25(4):403-7. PubMed ID: 2991153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of adrenal medullary opioid receptors. I. Binding of opioids to adrenal medullary opioid receptors].
    Murase H; Kamikubo K; Murayama M; Yasuda K; Tsurumi K; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1987 Jun; 63(6):727-40. PubMed ID: 2822499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydro-enkephalins. III. Synthesis and biological activity of [delta Ala2, Leu5]-enkephalin.
    Shimohigashi Y; Stammer CH
    Int J Pept Protein Res; 1982 Jan; 19(1):54-62. PubMed ID: 6288583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid receptors in bovine adrenal medulla.
    Dumont M; Lemaire S
    Can J Physiol Pharmacol; 1984 Oct; 62(10):1284-91. PubMed ID: 6095979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.